T-Cell Lymphomas Global Clinical Trials Review, H1, 2012

Summary

companys clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2012 provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating T-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 5
List of Figures 6
Introduction 7
T-Cell Lymphomas 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of T-Cell Lymphomas 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in T-Cell Lymphomas Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Allos Therapeutics, Inc. 32
Clinical Trial Overview of Allos Therapeutics, Inc. 32
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Seattle Genetics, Inc. 34
Clinical Trial Overview of Seattle Genetics, Inc. 34
Celgene Corporation 35
Clinical Trial Overview of Celgene Corporation 35
BioCryst Pharmaceuticals, Inc. 36
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 36
Ligand Pharmaceuticals, Inc. 37
Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 37
Eisai Inc. 38
Clinical Trial Overview of Eisai Inc. 38
TSD Japan, Inc. 39
Clinical Trial Overview of TSD Japan, Inc. 39
Spectrum Pharmaceuticals, Inc. 40
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 40
Solasia Pharma K.K. 41
Clinical Trial Overview of Solasia Pharma K.K. 41
TopoTarget A/S 42
Clinical Trial Overview of TopoTarget A/S 42
Genmab A/S 43
Clinical Trial Overview of Genmab A/S 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Millennium Pharmaceuticals, Inc. 45
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 45
Eli Lilly and Company 46
Clinical Trial Overview of Eli Lilly and Company 46
AstraZeneca PLC 47
Clinical Trial Overview of AstraZeneca PLC 47
Amgen Inc. 48
Clinical Trial Overview of Amgen Inc. 48
Clinical Trial Overview of Top Universities / Institutes / Hospitals 49
Fred Hutchinson Cancer Research Center 49
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 49
The University of Texas M. D. Anderson Cancer Center 51
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 51
Case Comprehensive Cancer Center 52
Clinical Trial Overview of Case Comprehensive Cancer Center 52
Mayo Clinic 53
Clinical Trial Overview of Mayo Clinic 53
Stanford University 54
Clinical Trial Overview of Stanford University 54
University of Nebraska 55
Clinical Trial Overview of University of Nebraska 55
Groupe dEtudes de Lymphomes de LAdulte 56
Clinical Trial Overview of Groupe dEtudes de Lymphomes de LAdulte 56
FUDAN University 57
Clinical Trial Overview of FUDAN University 57
Samsung Medical Center 58
Clinical Trial Overview of Samsung Medical Center 58
Zhengzhou University 59
Clinical Trial Overview of Zhengzhou University 59
NK-cell Tumor Study Group 60
Clinical Trial Overview of NK-cell Tumor Study Group 60
Alberta Health Services 61
Clinical Trial Overview of Alberta Health Services 61
The National Institute of Allergy and Infectious Diseases 62
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 62
Aarhus University 63
Clinical Trial Overview of Aarhus University 63
Memorial Sloan Kettering Cancer Center 64
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 64
Arizona Cancer Center 65
Clinical Trial Overview of Arizona Cancer Center 65
Wake Forest University 66
Clinical Trial Overview of Wake Forest University 66
Sun Yat-sen University 67
Clinical Trial Overview of Sun Yat-sen University 67
Albert Einstein College of Medicine of Yeshiva University 68
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 68
Ontario Clinical Oncology Group 69
Clinical Trial Overview of Ontario Clinical Oncology Group 69
Five Key Clinical Profiles 70
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About company 100
Contact Us 100
Disclaimer 100
Source 101

List of Tables

T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
T-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries, 2012* 16
T-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries, 2012* 17
T-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
T-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries, 2012* 19
T-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
T-Cell Lymphomas Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
T-Cell Lymphomas Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Allos Therapeutics, Inc., 2012* 32
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 33
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012* 34
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 35
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2012* 36
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Ligand Pharmaceuticals, Inc., 2012* 37
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 38
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by TSD Japan, Inc., 2012* 39
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2012* 40
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Solasia Pharma K.K., 2012* 41
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by TopoTarget A/S, 2012* 42
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Genmab A/S, 2012* 43
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 44
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012* 45
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 46
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 47
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 48
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 49
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 51
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 52
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 53
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 54
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2012* 55
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe dEtudes de Lymphomes de LAdulte, 2012* 56
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 57
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 58
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhengzhou University, 2012* 59
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by NK-cell Tumor Study Group, 2012* 60
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2012* 61
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012* 62
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 63
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 64
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Arizona Cancer Center, 2012* 65
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 66
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 67
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2012* 68
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Ontario Clinical Oncology Group, 2012* 69

List of Figures

T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
T-Cell Lymphomas Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
T-Cell Lymphomas Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
T-Cell Lymphomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
T-Cell Lymphomas Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
T-Cell Lymphomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
company Methodology 99